Head-to-head

BPC-157 vs GHK-Cu

A field-by-field comparison of BPC-157 and GHK-Cu drawn from the PeptideIndex database: mechanism, evidence grade, half-life, administration route, reported dosing, side effects, storage and legal status. They belong to different categories — recovery & repair and skin & hair — so this page focuses on what each one actually does rather than which is "better".

BPC-157 vs GHK-Cu at a glance

Attribute	BPC-157	GHK-Cu
Category	Recovery & repair	Skin & hair
Evidence grade	Emerging	Moderate
Also known as	Body Protection Compound 157, PL 14736	Copper peptide, Glycyl-L-histidyl-L-lysine copper
Chain	15 amino acids (GEPPPGKPADDAGLV)	Tripeptide (Gly-His-Lys) with copper(II)
Mechanism	Appears to upregulate growth-hormone receptor expression in tendon fibroblasts and promote angiogenesis via the VEGFR2–Akt–eNOS pathway, accelerating the formation of new blood vessels at an injury site. It also modulates nitric oxide signalling and appears protective of the gut lining.	Delivers copper into cells and resets gene expression toward a younger profile, upregulating collagen, elastin and glycosaminoglycan synthesis while activating antioxidant defences and hair-follicle enlargement.
Reported benefits	Faster tendon, ligament and muscle healing in rodent models · Protective effect on the gastrointestinal lining, including NSAID-induced damage · Reduced local inflammation around injury sites · Anecdotal relief from tendinopathy and joint pain	Increased collagen and elastin production · Improved skin firmness and reduced fine lines · Hair-follicle stimulation · Accelerated wound healing
Reported side effects	Injection-site irritation · Transient dizziness or nausea · Unknown long-term safety profile	Skin irritation or redness · Copper accumulation with excessive systemic use · Injection-site swelling
Half-life	Approximately 4 hours (stable oral form debated)	Not applicable topically; short systemically
Administration	Subcutaneous injection; oral capsules used for gut-specific goals	Topical serum, microneedling adjunct or subcutaneous injection
Dosing overview	Commonly cited in literature at 200–500 mcg once or twice daily for 4–8 weeks	Topical 1–3% serum daily; injectable protocols vary widely
Storage	Lyophilised powder refrigerated; reconstituted vials 2–8 °C, used within ~30 days	Cool, dark place; the solution is characteristically deep blue
Legal status	Not FDA-approved. Research-chemical status in most countries; prohibited in sport.	Widely available as a cosmetic ingredient; injectable use is unapproved.

Key differences between BPC-157 and GHK-Cu

Different categories, different goals

BPC-157 is indexed under recovery & repair, while GHK-Cu sits under skin & hair. They are not substitutes for one another: BPC-157 is described as "A synthetic fragment of a protein found in gastric juice, widely used in the recovery community for tendon, gut and soft-tissue complaints." and GHK-Cu as "A naturally occurring copper-binding tripeptide with the best-supported cosmetic profile of any peptide, plus hair and wound-healing uses."

Mechanism of action

BPC-157: Appears to upregulate growth-hormone receptor expression in tendon fibroblasts and promote angiogenesis via the VEGFR2–Akt–eNOS pathway, accelerating the formation of new blood vessels at an injury site. It also modulates nitric oxide signalling and appears protective of the gut lining. GHK-Cu: Delivers copper into cells and resets gene expression toward a younger profile, upregulating collagen, elastin and glycosaminoglycan synthesis while activating antioxidant defences and hair-follicle enlargement.

Evidence quality is not equal

BPC-157 carries a Emerging evidence grade and GHK-Cu a Moderate grade on this index. The grade describes the quality of published human data, not how well a compound works — GHK-Cu has the better-documented record of the two, and claims made about BPC-157 rest on thinner human evidence.

Half-life and dosing frequency

BPC-157 is listed at approximately 4 hours (stable oral form debated); GHK-Cu at not applicable topically; short systemically. That difference is what drives the reported schedules: Commonly cited in literature at 200–500 mcg once or twice daily for 4–8 weeks versus Topical 1–3% serum daily; injectable protocols vary widely

Route of administration

BPC-157 is administered by subcutaneous injection; oral capsules used for gut-specific goals. GHK-Cu is administered by topical serum, microneedling adjunct or subcutaneous injection.

Legal and regulatory status differs

BPC-157: Not FDA-approved. Research-chemical status in most countries; prohibited in sport. GHK-Cu: Widely available as a cosmetic ingredient; injectable use is unapproved. This is usually the most practical difference between two compounds, because it determines whether a supply chain is labelled and regulated at all.

Handling and storage

BPC-157 is stored lyophilised powder refrigerated; reconstituted vials 2–8 °c, used within ~30 days. GHK-Cu is stored cool, dark place; the solution is characteristically deep blue.

What BPC-157 and GHK-Cu have in common

On the attributes tracked in this database — category, evidence grade, mechanism, half-life, administration, dosing overview, storage and legal status — BPC-157 and GHK-Cu share no identical values. They are compared here because they come up together in the same searches, not because they overlap.

Each compound in brief

BPC-157

Recovery & repair · Emerging evidence

A synthetic fragment of a protein found in gastric juice, widely used in the recovery community for tendon, gut and soft-tissue complaints.

Considerations: Nearly all evidence is preclinical (rodent); robust human trials are absent · Injected near the injury site is the common anecdotal practice, though systemic effects are proposed · Banned by WADA for competing athletes

GHK-Cu

Skin & hair · Moderate evidence

A naturally occurring copper-binding tripeptide with the best-supported cosmetic profile of any peptide, plus hair and wound-healing uses.

Considerations: Topical formulations are the safest starting point · Do not combine directly with vitamin C or strong acids in the same layer · Injectable use can cause significant flushing and irritation